Studies

Meltzer-Gunnes CJ, Hagen MC, Wang Y, Jensen PT, Vistad I (2025)
Long-term quality of life, vulvar symptoms, and sexual functioning: A cross-sectional study of Norwegian vulvar cancer survivors
Acta Obstet Gynecol Scand (in press)
DOI 10.1111/aogs.15155, PubMed 40366224

Støer NC, Botteri E, Lindemann K, Langseth H, Fortner RT (2025)
Low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs and epithelial ovarian cancer survival: a registry-based cohort study in Norway
BMC Cancer, 25 (1), 807
DOI 10.1186/s12885-025-14168-y, PubMed 40307814

Poveda A, Lheureux S, Colombo N, Cibula D, Elstrand M, Weberpals J, Bjurberg M, Oaknin A, Sikorska M, González-Martín A, Madry R, Rubio Pérez MJ, Ledermann J, Romero I, Özgören O, Barnicle A, Marshall H, Bashir Z, Škof E (2025)
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trial
Gynecol Oncol, 197, 74-82 (in press)
DOI 10.1016/j.ygyno.2025.04.580, PubMed 40300425